ORELABRUTINIB for Mantle cell lymphoma: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 7 adverse event reports in the FDA FAERS database where ORELABRUTINIB was used for Mantle cell lymphoma.
Most Reported Side Effects for ORELABRUTINIB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Anaemia | 54 | 41.2% | 8 | 5 |
| Hypokalaemia | 40 | 30.5% | 2 | 0 |
| Pneumonia | 35 | 26.7% | 8 | 3 |
| Neutropenia | 30 | 22.9% | 3 | 0 |
| Thrombocytopenia | 26 | 19.9% | 5 | 0 |
| Disease progression | 14 | 10.7% | 3 | 0 |
| Covid-19 | 11 | 8.4% | 8 | 0 |
| Platelet count decreased | 11 | 8.4% | 4 | 7 |
| Drug ineffective | 10 | 7.6% | 6 | 0 |
| Myelosuppression | 10 | 7.6% | 1 | 3 |
| Product use in unapproved indication | 8 | 6.1% | 1 | 0 |
| White blood cell count decreased | 8 | 6.1% | 1 | 2 |
| Atrial fibrillation | 7 | 5.3% | 1 | 0 |
| Febrile neutropenia | 7 | 5.3% | 2 | 0 |
| Neutrophil count decreased | 7 | 5.3% | 1 | 2 |
Other Indications for ORELABRUTINIB
Diffuse large b-cell lymphoma (66)
Central nervous system lymphoma (31)
B-cell lymphoma (9)
Chronic lymphocytic leukaemia (7)
Non-hodgkin's lymphoma (5)
Other Drugs Used for Mantle cell lymphoma
IBRUTINIB (6,306)
RITUXIMAB (3,940)
LENALIDOMIDE (2,989)
CYCLOPHOSPHAMIDE (1,815)
DOXORUBICIN (1,396)
VENETOCLAX (1,367)
VINCRISTINE (1,361)
BENDAMUSTINE (1,227)
CYTARABINE (1,174)
DEXAMETHASONE (949)